Abstract
Sorafenib is a multikinase inhibitor that is used to treat hepatocellular carcinoma by inhibiting tumor cell growth and angiogenesis. Cutaneous advers......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
